http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19828273-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-939
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-58
filingDate 1998-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2af557e3e978abc51b41c9b896535551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22f9edc70cc15af6ce67263117a93500
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4e44c2f87f84d2910314bac7e19dc36
publicationDate 1999-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-19828273-A1
titleOfInvention Transdermal therapeutic system containing hormones and crystallization inhibitors
abstract A transdermal therapeutic system in plaster form for the controlled release of estradiol in combination with norethisterone acetate, comprising a backing layer, an associated reservoir, which is supersaturated with active substances, which is produced using polyacrylate pressure sensitive adhesives and crystallization inhibitors, and a removable protective layer, are characterized in that that the crystallization inhibitor is an amino group-containing polymer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10025971-B4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10025971-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6750291-B2
priorityDate 1998-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9300058-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19728517-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413952003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448008838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451113904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424991118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425654805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9818306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421889135
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421328696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21414
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107676

Total number of triples: 54.